Surface proteome mining for identification of potential vaccine candidates against Campylobacter jejuni: an in silico approach
Campylobacter jejuni remains a major cause of human gastroenteritis with estimated annual incidence rate of 450 million infections worldwide. C. jejuni is a major burden to public health in both socioeconomically developing and industrialized nations. Virulence determinants involved in C. jejuni pathogenesis are multifactorial in nature and not yet fully understood. Despite the completion of the first C. jejuni genome project in 2000, there are currently no vaccines in the market against this pathogen. Traditional vaccinology approach is an arduous and time extensive task. Omics techniques coupled with sequencing data have engaged researcher’s attention to reduce the time and resources applied in the process of vaccine development. Recently, there has been remarkable increase in development of in silico analysis tools for efficiently mining biological information obscured in the genome. In silico approaches have been crucial for combating infectious diseases by accelerating the pace of vaccine development. This study employed a range of bioinformatics approaches for proteome scale identification of peptide vaccine candidates. Whole proteome of C. jejuni was investigated for varied properties like antigenicity, allergenicity, major histocompatibility class (MHC)–peptide interaction, immune cell processivity, HLA distribution, conservancy, and population coverage. Predicted epitopes were further tested for binding in MHC groove using computational docking studies. The predicted epitopes were conserved; covered more than 80 % of the world population and were presented by MHC-I supertypes. We conclude by underscoring that the epitopes predicted are believed to expedite the development of successful vaccines to control or prevent C. jejuni infections albeit the results need to be experimentally validated.
KeywordsC. jejuni Vaccine candidates Reverse vaccinology Antigenicity Allergenicity Docking
Compliance with ethical standards
This research was supported by FAST TRACK Young Scientist Fellowship from DST (Department of Science and Technology), Ministry of Science and Technology, India, under the grant number SB/FT/LS-278/2012.
Conflict of interest
We confirm that there are no conflicts of interest associated with this publication. Ethical Approval and Informed Consent statements are not applicable to our manuscript.
- Albert MJ (2014) Vaccines against Campylobacter jejuni. Austin J Clin Immunol 1:1013Google Scholar
- Doro F, Liberatori S, RodrãGuez-Ortega MJ, Rinaudo CD, Rosini R, Mora M, Scarselli M, Altindis E, D’aurizio R, Stella M, Margarit I, Maione D, Telford JL, Norais N, Grandi G (2009) Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for group b streptococcus hypervirulent strain COH1. Mol Cell Proteomics 8:1728–1737CrossRefPubMedPubMedCentralGoogle Scholar
- Friedman CR, Neimann J, Wegener HC, Tauxe RV (2000) Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Campylobacter. ASM International, Washington, pp 121–138Google Scholar
- Giuliani MM, Adu-Bobie J, Comanducci M, Aricã B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 103:10834–10839CrossRefPubMedPubMedCentralGoogle Scholar
- Li X, Yang H-W, Chen H, Wu J, Liu Y, Wei J-F (2014) In silico prediction of T and B cell epitopes of Der f 25 in Dermatophagoides farinae. Int J Genomics 2014:10Google Scholar
- Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D’Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Dei VN, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G (2005) Identification of a universal group B streptococcus vaccine by multiple genome screen. Science (New York, NY) 309:148–150CrossRefGoogle Scholar
- O’ryan M, Vidal R, Del Canto F, Carlos SJ, Montero D (2015) Vaccines for viral and bacterial pathogens causing acute gastroenteritis: part II: vaccines for shigella, salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. Hum Vaccin Immunother 11:601–619CrossRefPubMedPubMedCentralGoogle Scholar
- Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, Van Vliet AHM, Whitehead S, Barrell BG (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665–668CrossRefPubMedGoogle Scholar
- Schrodinger, Llc (2010) The PyMOL molecular graphics system, Version 1.3r1Google Scholar
- Thakur S, Zhao S, Mcdermott PF, Harbottle H, Abbott J, English L, Gebreyes WA, White DG (2010) Antimicrobial resistance, virulence, and genotypic profile comparison of Campylobacter jejuni and Campylobacter coli isolated from humans and retail meats. Foodborne Pathog Dis 7:835–844CrossRefPubMedGoogle Scholar
- Yu NY, Wagner JR, Laird MR, Melli G, Rey SB, Lo R, Dao P, Sahinalp SC, Ester M, Foster LJ, Brinkman FSL (2010) PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26:1608–1615CrossRefPubMedPubMedCentralGoogle Scholar
- Zeng X, Xu F, Lin J (2010) Development and evaluation of CmeC subunit vaccine against Campylobacter jejuni. J Vaccines Vaccination 1:112Google Scholar